Why the study?
What are the clinical and pathologic differences between nonfamilial and familial cardiac myxoma?
What are the clinical and pathologic differences between nonfamilial and familial cardiac myxoma?
Familial and nonfamilial cardiac myxomas exhibit distinct clinical and pathologic profiles, with familial cases presenting earlier in life, more often in men, and with a higher likelihood of multicentricity and associated syndromes.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to evaluate young men with multicentric myxomas for syndromes; leaves open optimal genetic screening protocols.
Comparison of certain clinical and pathologic features among patients who have nonfamilial cardiac myxoma with those of patients who have familial cardiac myxoma showed statistically significant differences. Nonfamilial cardiac myxoma was a disorder of middle-aged (mean age, 51 years) women (76%), usually occurred in the left atrium (86%) as a single tumor (94%), and had no particular associated conditions. Familial cardiac myxoma, on the other hand, was a disorder of young (mean age, 24 years) men (66%), was less commonly in the left atrium (62%), was often multicentric (33%), and was occasionally associated with unusual or rare conditions (20%).
No takes yet. Share an insight, caveat, or question.
J. Aidan Carney (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: